Company Certara, Inc.

Equities

CERT

US15687V1098

Software

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
16.45 USD -1.67% Intraday chart for Certara, Inc. -2.95% -6.48%

Business Summary

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

Number of employees: 1,365

Sales per Business

USD in Million2022Weight2023Weight Delta
Services
62.8 %
220 65.6 % 223 62.8 % +1.13%
Software
37.2 %
115 34.4 % 132 37.2 % +14.04%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
73.0 %
248 74.0 % 259 73.0 % +4.14%
EMEA
17.9 %
57 17.0 % 64 17.9 % +11.52%
Asia Pacific
7.3 %
26 7.7 % 26 7.3 % -0.05%
Americas
1.8 %
5 1.4 % 6 1.8 % +40.77%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 19-05-31
Director of Finance/CFO 51 23-03-31
President 60 20-08-31
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 21-05-16
Corporate Officer/Principal 53 19-12-31
Human Resources Officer - 21-07-12
General Counsel 53 18-02-28
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 57 17-07-31
Director/Board Member 65 21-07-31
Chief Executive Officer 54 19-05-31
Director/Board Member 65 22-07-10
Chairman 70 18-04-30
Director/Board Member 66 12-12-31
Director/Board Member 65 22-12-07
Director/Board Member 64 22-07-20
Director/Board Member 69 21-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 160,627,709 119,048,532 ( 74.11 %) 436,615 ( 0.2718 %) 74.11 %

Shareholders

NameEquities%Valuation
Arsenal Capital Management LP
22.74 %
36,345,835 22.74 % 650 M $
BlackRock Advisors LLC
8.339 %
13,329,999 8.339 % 238 M $
Vanguard Fiduciary Trust Co.
7.847 %
12,544,560 7.847 % 224 M $
Mubadala Investment Co. (Investment Company)
6.015 %
9,615,384 6.015 % 172 M $
Baillie Gifford & Co.
5.581 %
8,921,463 5.581 % 160 M $
William Blair Investment Management LLC
4.405 %
7,042,316 4.405 % 126 M $
Wasatch Advisors, Inc.
3.081 %
4,924,845 3.081 % 88 M $
ArrowMark Colorado Holdings LLC
2.629 %
4,202,922 2.629 % 75 M $
ClearBridge Investments LLC
2.590 %
4,140,349 2.590 % 74 M $
JPMorgan Investment Management, Inc.
2.507 %
4,008,269 2.507 % 72 M $

Company contact information

Certara, Inc.

100 Overlook Center Suite 101

08540, Princeton

+

http://www.certara.com
address Certara, Inc.(CERT)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
16.45 USD
Average target price
19.74 USD
Spread / Average Target
+20.00%
Consensus